On Statistical Principles for Clinical Trials in Pharmaceutical Development-A Review of China FDA Draft Guidance

Pharmaceutical Regulatory Affairs: Open Access
doi 10.4172/2167-7689.1000152
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

FDA Issues Draft Guidance on MRD Testing

Cancer Discovery
Oncology
2018English

Draft Guidance on Clinical Trials Recognises Needs of Non-Commercial Research

BMJ
2004English

Significance Level and the Number of Trials in Confirmatory Clinical Trials in Relation to “Statistical Principles for Clinical Trials”

Japanese Journal of Biometrics
2003English

Implications of the FDA Draft Guidance on Biosimilars for Clinicians: What We Know and Don't Know

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2013English

EUPATI and Patients in Medicines Research and Development: Guidance for Patient Involvement in Ethical Review of Clinical Trials

Frontiers in Medicine
Medicine
2018English

FDA Oversight of Cell Therapy Clinical Trials

Science Translational Medicine
Medicine
2012English

Patient Reported Outcomes (PROs) in Clinical Trials: Is ‘In-Trial’ Guidance Lacking? A Systematic Review

PLoS ONE
Multidisciplinary
2013English

Informed Consent for Clinical Trials: A Review

East African Medical Journal
Medicine
2010English

Data Sharing in Clinical Trials – Practical Guidance on Anonymising Trial Datasets

Trials
MedicinePharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy